A deeper understanding of the mechanisms by which the GR, AR, estrogen receptor (ER), progesterone receptor (PR), and mineralocorticoid receptor (MR) affect immune cells will help the development of novel therapies employing immune cell type- and gender-specific perturbations for the treatment of cancer, as well as other diseases. Here, NR3C2 is linked to cancer.